225 related articles for article (PubMed ID: 26304108)
21. Design, synthesis and antimicrobial activities evaluation of Schiff base derived from secnidazole derivatives as potential FabH inhibitors.
Li Y; Zhao CP; Ma HP; Zhao MY; Xue YR; Wang XM; Zhu HL
Bioorg Med Chem; 2013 Jun; 21(11):3120-6. PubMed ID: 23602519
[TBL] [Abstract][Full Text] [Related]
22. Discovery of novel dinitrobenzotrifluoride containing o-hydroxybenzylamine derivatives as potential antibacterial agents.
Li QS; Ni HJ; Yang Y; Lv XH; Ruan BF
Med Chem; 2015; 11(3):305-13. PubMed ID: 25219926
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antibacterial activity of 4-benzoyl-1-methyl-5-phenyl-1H-pyrazole-3-carboxylic acid and derivatives.
Akbas E; Berber I; Sener A; Hasanov B
Farmaco; 2005 Jan; 60(1):23-6. PubMed ID: 15652364
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, antimicrobial evaluation and QSAR studies of 2-chlorobenzoic acid derivatives.
Mehta S; Kumar P; Marwaha RK; Narasimhan B
Drug Res (Stuttg); 2014 Apr; 64(4):208-13. PubMed ID: 24258706
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
Cheng K; Xue JY; Zhu HL
Bioorg Med Chem Lett; 2013 Jul; 23(14):4235-8. PubMed ID: 23731945
[TBL] [Abstract][Full Text] [Related]
26. New substituted pyrazolones and dipyrazolotriazines as promising tyrosyl-tRNA synthetase and peroxiredoxin-5 inhibitors: Design, synthesis, molecular docking and structure-activity relationship (SAR) analysis.
Othman IMM; Gad-Elkareem MAM; Hassane Anouar E; Aouadi K; Snoussi M; Kadri A
Bioorg Chem; 2021 Apr; 109():104704. PubMed ID: 33609915
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors.
Liu JJ; Sun J; Fang YB; Yang YA; Jiao RH; Zhu HL
Org Biomol Chem; 2014 Feb; 12(6):998-1008. PubMed ID: 24382549
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antimicrobial evaluation of new phenoxyacetamide derivatives.
Raffa D; Migliara O; Daidone G; Maggio B; Schillaci D
Boll Chim Farm; 2002; 141(1):3-7. PubMed ID: 12064055
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea.
Zhang HJ; Qin X; Liu K; Zhu DD; Wang XM; Zhu HL
Bioorg Med Chem; 2011 Sep; 19(18):5708-15. PubMed ID: 21872479
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, characterization and antimicrobial activity of water-soluble silver(i) complexes of metronidazole drug and selected counter-ions.
Kalinowska-Lis U; Felczak A; Chęcińska L; Zawadzka K; Patyna E; Lisowska K; Ochocki J
Dalton Trans; 2015 May; 44(17):8178-89. PubMed ID: 25846722
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
Zhang F; Wen Q; Wang SF; Shahla Karim B; Yang YS; Liu JJ; Zhang WM; Zhu HL
Bioorg Med Chem Lett; 2014 Jan; 24(1):90-5. PubMed ID: 24332628
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and biological evaluation of chrysin derivatives as potential FabH inhibitors.
Li HX; Wang ZC; Qian YM; Yan XQ; Lu YD; Zhu HL
Chem Biol Drug Des; 2017 Jan; 89(1):136-140. PubMed ID: 27860280
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and Antimicrobial Activity of the Hybrid Molecules between Sulfonamides and Active Antimicrobial Pleuromutilin Derivative.
Chen L; Yang D; Pan Z; Lai L; Liu J; Fang B; Shi S
Chem Biol Drug Des; 2015 Aug; 86(2):239-45. PubMed ID: 25431015
[TBL] [Abstract][Full Text] [Related]
34. Remarkable substituent effects on antimicrobial activities of 1,3-diorganylimidazolidinium salts.
Cetinkaya E; Denizci A; Ozdemir I; Oztürk HT; Karaboz I; Cetinkaya B
J Chemother; 2002 Jun; 14(3):241-5. PubMed ID: 12120877
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of Staphylococcus aureus tyrosyl-tRNA synthetase in complex with a class of potent and specific inhibitors.
Qiu X; Janson CA; Smith WW; Green SM; McDevitt P; Johanson K; Carter P; Hibbs M; Lewis C; Chalker A; Fosberry A; Lalonde J; Berge J; Brown P; Houge-Frydrych CS; Jarvest RL
Protein Sci; 2001 Oct; 10(10):2008-16. PubMed ID: 11567092
[TBL] [Abstract][Full Text] [Related]
36. Tyrosyl-tRNA synthetase inhibitors: a patent review.
Sun J; Lv PC; Zhu HL
Expert Opin Ther Pat; 2017 May; 27(5):557-564. PubMed ID: 27977303
[TBL] [Abstract][Full Text] [Related]
37. Structure-based design, synthesis, and biological evaluation of isatin derivatives as potential glycosyltransferase inhibitors.
Wang Y; Chan FY; Sun N; Lui HK; So PK; Yan SC; Chan KF; Chiou J; Chen S; Abagyan R; Leung YC; Wong KY
Chem Biol Drug Des; 2014 Dec; 84(6):685-96. PubMed ID: 24890564
[TBL] [Abstract][Full Text] [Related]
38. Systematic study of non-natural short cationic lipopeptides as novel broad-spectrum antimicrobial agents.
Lohan S; Cameotra SS; Bisht GS
Chem Biol Drug Des; 2013 Nov; 82(5):557-66. PubMed ID: 23819506
[TBL] [Abstract][Full Text] [Related]
39. Amino acid conjugated antimicrobial drugs: Synthesis, lipophilicity- activity relationship, antibacterial and urease inhibition activity.
Ullah A; Iftikhar F; Arfan M; Batool Kazmi ST; Anjum MN; Haq IU; Ayaz M; Farooq S; Rashid U
Eur J Med Chem; 2018 Feb; 145():140-153. PubMed ID: 29324337
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of a class of new coumarin triazole derivatives as potential antimicrobial agents.
Shi Y; Zhou CH
Bioorg Med Chem Lett; 2011 Feb; 21(3):956-60. PubMed ID: 21215620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
